Insider · CIK 0001310845
Robert A Beardsley
Files at ABUS (Arbutus Biopharma Corp). First filing -, latest -.
Robert A Beardsley files SEC Form 4 as director at ABUS (Arbutus Biopharma Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert A Beardsley has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | ABUS Arbutus Biopharma Corp | DDisposition to issuer Common Shares | -17,948 | $5.00 | $90k | 14,328 | 6 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Common Shares | +52,533 | $3.20 | $168k | 52,533 | 20 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Common Shares | +78,800 | $4.24 | $334k | 131,333 | 20 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | FTax withholding Common Shares | -99,057 | $5.07 | $502k | 32,276 | 20 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Stock Option (Right to Buy)derivative | -52,533 | $0.00 | $0 | 105,067 | 20 d ago |
| Sep 18, 2026 | ABUS Arbutus Biopharma Corp | MOption exercise Stock Option (Right to Buy)derivative | -78,800 | $0.00 | $0 | 0 | 20 d ago |
| Jun 8, 2026 | ABUS Arbutus Biopharma Corp | AGrant or award Stock Option (Right to Buy)derivative | +78,800 | $0.00 | $0 | 78,800 | Jun 10, 2026 |
| Mar 18, 2025 | ABUS Arbutus Biopharma Corp | AGrant or award Stock Option (Right to Buy)derivative | +157,600 | $0.00 | $0 | 157,600 | Mar 20, 2025 |
Questions about Robert A Beardsley
Answered from the filings on this page, as of the latest one.
Is Robert A Beardsley buying or selling?
Robert A Beardsley has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert A Beardsley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert A Beardsley has 0.
Where does Robert A Beardsley file Form 4?
Robert A Beardsley has filed Form 4 at ABUS (Arbutus Biopharma Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.